VT
AMRX icon

Vise Technologies’s Amneal Pharmaceuticals AMRX Stock Holding History

Vise Technologies’s Portfolio AMRX Stock Details AMRX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$475K Buy
27,420
+17,265
+170% +$237K 0.01% 1184
2026
Q1 		$128K Hold
10,155
– – ﹤0.01% 1413
2025
Q4 		$128K Buy
+10,155
New +$116K ﹤0.01% 1426

Other funds holding AMRX

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
TGA
TPG GP A Fort Worth, Texas $5B AUM 58.56% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
RCMNY
Rubric Capital Management (New York) New York $10.9B AUM 70.31% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
State Street
State Street Boston, Massachusetts $3.38T AUM 44.17% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $552B AUM 44.19% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
Neuberger Berman Group
Neuberger Berman Group New York $150B AUM 40.08% 1-Year Est. Return

Vise Technologies's AMRX Position: Q2 2026 in Review

Vise Technologies increased its Amneal Pharmaceuticals (AMRX) stake by 170% in Q2 2026, buying an estimated $237K and bringing the position to 27,420 shares worth $475K. The position accounts for 0.01% of the portfolio, ranked #1184.

Vise Technologies first reported a position in AMRX in Q4 2025 and has held it in 3 quarters since. 311 funds tracked by Wall St. Rank hold AMRX as of Q2 2026.

  • Vise Technologies held 27,420 shares of Amneal Pharmaceuticals worth $475K as of Q2 2026.
  • Vise Technologies bought 17,265 Amneal Pharmaceuticals shares in Q2 2026, an estimated $237K.
  • Amneal Pharmaceuticals made up 0.01% of Vise Technologies's portfolio in Q2 2026, its #1184 holding.
  • Vise Technologies first reported a position in Amneal Pharmaceuticals in Q4 2025 and has held it in 3 quarters since.
  • 311 funds tracked by Wall St. Rank held Amneal Pharmaceuticals as of Q2 2026.

Based on Vise Technologies's 13F filing for Q2 2026, filed 11 Aug 2026.